A multiple-dose toxicity study of tanezumab in cynomolgus monkeys. (Q51529943)

6 April 2018

title

A multiple-dose toxicity study of tanezumab in cynomolgus monkeys. (English)

1 reference

6 April 2018

author name string

Mark Zorbas

1

1 reference

6 April 2018

Susan Hurst

2

1 reference

6 April 2018

David Shelton

3

1 reference

6 April 2018

Mark Evans

4

1 reference

6 April 2018

Deborah Finco

5

1 reference

6 April 2018

Mark Butt

6

1 reference

6 April 2018

language of work or name

English

0 references

publication date

3 December 2010

1 reference

6 April 2018

Regulatory Toxicology and Pharmacology

published in

1 reference

6 April 2018

volume

59

1 reference

6 April 2018

issue

2

1 reference

6 April 2018

page(s)

334-342

1 reference

6 April 2018

Probing the binding mechanism and affinity of tanezumab, a recombinant humanized anti-NGF monoclonal antibody, using a repertoire of biosensors

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.11.005

Analysis of the effects of the antiserum to the nerve growth factor in adult mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.11.005

A study of the de- and regenerative changes in the sympathetic nervous system of the adult mouse after treatment with the antiserum to nerve growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.11.005

Incidences and range of spontaneous findings in control cynomolgus monkeys (Macaca fascicularis) used in toxicity studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.11.005

PURIFICATION OF A NERVE-GROWTH PROMOTING PROTEIN FROM THE MOUSE SALIVARY GLAND AND ITS NEURO-CYTOTOXIC ANTISERUM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.11.005

NGF effects on hot plate behaviors in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.11.005

Effects of long-term nerve growth factor deprivation on the nervous system of the adult rat: An experimental autoimmune approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.11.005

A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.11.005

Novel class of pain drugs based on antagonism of NGF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.11.005

Nerve growth factor sequestering therapy attenuates non-malignant skeletal pain following fracture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.11.005

Destruction of sympathetic and sensory neurons in the developing rat by a monoclonal antibody against the nerve growth factor (NGF) receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.11.005

Effects of a monoclonal antibody raised against nerve growth factor on skeletal pain and bone healing after fracture of the C57BL/6J mouse femur

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.11.005

Tanezumab for the treatment of pain from osteoarthritis of the knee.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.11.005

DESTRUCTION OF THE SYMPATHETIC GANGLIA IN MAMMALS BY AN ANTISERUM TO A NERVE-GROWTH PROTEIN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.11.005

Nerve growth factor-induced hyperalgesia in the neonatal and adult rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.11.005

Antibody pharmacokinetics and pharmacodynamics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.11.005

The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.11.005

Use of an experimental autoimmune model to define nerve growth factor dependency of peripheral and central substance P-containing neurons in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.11.005

Nerve growth factor regulates sympathetic ganglion cell morphology and survival in the adult mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.11.005

Effect of anti-NGF antibodies in a rat tibia fracture model of complex regional pain syndrome type I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.11.005

Immunogenicity of therapeutic proteins: clinical implications and future prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.11.005

Effect of exposure to anti-NGF on sensory neurons of adult rats and guinea pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.11.005

Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.11.005

Nerve growth factor mediates hyperalgesia and cachexia in auto-immune arthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.11.005

Targeting nerve growth factor in pain: what is the therapeutic potential?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.11.005

Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2010.11.005

10.1016/J.YRTPH.2010.11.005

7 January 2021

Identifiers

DOI

1 reference

6 April 2018

PubMed ID

21130822

1 reference

6 April 2018